Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
PrEP Use Among Gay and Bi Men Hits a New High

A third of at-risk gay and bi men are now using Truvada for HIV prevention, the CDC says.

Published
21 March 2019
From
Poz
People stay on PrEP for 14 months on average in the US, study finds

Whether HIV pre-exposure prophylaxis (PrEP) is effective depends on whether people take it appropriately, at the times when they are at risk of HIV. But we know

Published
10 March 2019
By
Gus Cairns
PrEP use jumps to 35 percent among gay and bi men at risk of HIV

A third of gay and bisexual men use PrEP for HIV prevention, and nine in 10 are aware of it, but the CDC says the drug is still underused.

Published
08 March 2019
From
NBCNews.com
How many people who have used PrEP get HIV the same year? New York study finds out

One question often asked about pre-exposure prophylaxis (PrEP) use is how frequently people start PrEP while unknowingly having HIV, often because they have acquired it so recently

Published
07 March 2019
By
Gus Cairns
Scotland's introduction of HIV drug PrEP 'puts England to shame'

Campaigners who want to see HIV PrEP (HIV Pre-Exposure Prophylaxis) made similarly available elsewhere in the UK say that Scotland’s initial success “puts England’s sluggish delivery to shame”.

Published
28 February 2019
From
The Guardian
Major shift in HIV war as Kenyans now top users of prevention pill

About 54,000 Kenyans are using the daily HIV prevention pill today up from 9,000 a year ago. This is the second highest use in the world after US, which has 197,000 users in a population of 325 million.

Published
27 February 2019
From
The Standard
Men who have sex with men in China are unsure about PrEP

Gay men in China could benefit from more information around PrEP to increase uptake and curb new HIV infections in this group.

Published
24 February 2019
From
AVERT
Cocaine use associated with poor adherence to PrEP and dropping out of care

Cocaine users have poorer adherence to HIV pre-exposure prophylaxis (PrEP) and engagement with care, according to research published in the online edition of the Journal of Acquired

Published
22 February 2019
By
Michael Carter
In the USA, only two in five PrEP users keep taking it over two years

Real-world data from a large American chain of retail pharmacies show that only two in five people keep on taking pre-exposure prophylaxis (PrEP) for two years after

Published
21 February 2019
By
Roger Pebody
Gay men in New York rate an undetectable viral load as less effective than PrEP

Gay, bisexual and other men who have sex with men in New York City rate daily pre-exposure prophylaxis (PrEP) as the most effective HIV prevention strategy when

Published
19 February 2019
By
Roger Pebody
← First12345...8Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.